echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Roche collaborates to develop brain-penetrating oral small molecules for neurodegenerative diseases

    Roche collaborates to develop brain-penetrating oral small molecules for neurodegenerative diseases

    • Last Update: 2022-05-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Aquinnah announced today that it has entered into an R&D agreement with Roche to advance the development of brain-penetrating oral small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases


    Stress granules are one way the body repairs itself after damage


    Aquinnah's scientific team examined more than 250,000 compounds and found a variety of compounds that can clear stress granules, some of which can clear stress granules that contain the TDP-43 protein


    Under the agreement, Aquinnah and Roche will collaborate on research activities until the selection of a lead drug candidate, after which Roche will be responsible for further research, development and global commercialization


    References:

    [1] AQUINNAH PHARMACEUTICALS ANNOUNCES COLLABORATION WITH ROCHE TO ADVANCE NEW THERAPIES FOR ALS AND OTHER NEURODEGENERATIVE DISEASES.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.